手术联合血管内介入治疗原发性肝癌外科的临床价值  

THE CLINICAL VALUE OF SURGERY AND ENDOVASCULAR IN TREATING PRIMARY HEPATIC CARCINOMA SURGICAL

作　　者：欧涛[1] 尹海滨[1] 王文尖[1] 

机构地区：[1]海南省第三人民医院肿瘤放疗科,三亚572000

出　　处：《现代预防医学》2009年第24期4682-4683,共2页Modern Preventive Medicine

摘　　要：[目的]探讨手术联合血管内介入治疗原发性肝癌外科的临床应用价值。[方法]在本文对收治的原发性肝癌患者采用手术联合血管内介入治疗。[结果]观察组患者在治疗1年生存率达100.00%,两年生存率达92.59%,3年生存率达70.37%,4年生存率达11.11%;中位生存期为42.1月;平均生存期为41.8月。生存率、中位生存期和平均生存期均明显高于对照组(P﹤0.05)。表明手术联合血管内加入疗法治疗原发性肝癌的临床效果明显好于单纯的手术治疗。[结论]在术前行TACE有利于争取手术机会和手术根治,而术后应用则可以减少复发,有利于提高患者的生存率和生存期,手术切除联合血管内介入治疗是提高原发性肝癌整体疗效、存活率和生存期的重要方法,具有重要的临床应用价值。[Objective] To explore the clinical value of surgery and endovascular in treating primary hepatic carcinoma surgical.[Methods] In this paper,primary hepatic carcinoma patients were treated by combining surgery with endovascular.[Results] In the observation group,one-year survival rate reached to 100.00%,two-year survival rate was up to 92.59%,three-year survival rate reached to 70.37%,and four-year survival rate was up to 11.11%.The median survival time was 42.1 months.The average survival time was 41.8 months.Survival rate,median survival and mean survival time were significantly higher than those of control group（P ﹤ 0.05）.This showed that the clinical effect of surgery combined with endovascular in treating primary hepatic carcinoma was significantly better than the simple surgery.[Conclusion] The preoperative TACE lines have the opportunity to contribute to the achievement and surgical radical surgery,reduce the postoperative recurrence and help to improve the survival rate.Surgical excision combined with endovascular treatment for patients with primary hepatic carcinoma could improve the overall efficacy,survival,which is of great value in clinical application.

关 键 词：手术切除 肝动脉栓塞化疗 原发性肝癌 

分 类 号：R735.7[医药卫生—肿瘤]